Navidea Biopharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
NAVB on OTC
Industry
In Vitro & In Vivo Diagnostic Substances
Location
4995 Bradenton Avenue, Suite 240, Dublin, OH

There are no Buy or Sell transactions made by insiders since 11/8/2023

Navidea Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John K. Scott Jr. Director, 10%+ Owner $2.8M Nov 27, 2023
Craig Dais Chief Financial Officer $85.7K Nov 10, 2023
Jill Stefanelli Director $82.9K Nov 16, 2023
Dana J. Moss Director $76.3K Nov 16, 2023
Malcolm G. Witter Director $14.5K Nov 30, 2022
Amit Bhalla Director $6.32K Nov 30, 2022
L. Cappello Director $5.96K Nov 30, 2022
Michael S. Rosol Chief Medical Officer $5.9K Sep 9, 2022
Agnieszka Winkler Director $2.96K Nov 15, 2021
Thomas F. Farb Director $2.94K Nov 15, 2021
Joshua M. Wilson Director $2.64K Nov 29, 2022
Sarah Kathryn Rouan Director $1.61K Jun 30, 2021
Claudine Bruck Director $1.45K Jun 30, 2021
Michel Mikhail Chief Regulatory Officer Nov 15, 2021

Recent Insider Transactions by Companies or Individuals for Navidea Biopharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.